Replies to post #654263 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

Ever since Dr. Duffy stopped in at NWBO and returned to Merck, went to Regeneron then apparently moved again it seems he has been on a scouting mission toward developing strategic partners for the best path forward with L and Direct. Of course milking the checkpoint inhibitor line before moving away from that is probably the desired route by any big pharma with them even if not the most efficacious or safest strategy in all cases so we really should stay vigilant for the sake of patients. Best wishes.

[attilathehunt]

"one might wonder why the publisher, and not NWBO gets the last independent edits followed by submission?"

LP and team will be the last review before submission.